JPMorgan Chase & Co. Reiterates “Underweight” Rating for Cognex (NASDAQ:CGNX)

Cognex (NASDAQ:CGNX)‘s stock had its “underweight” rating restated by JPMorgan Chase & Co. in a research note issued to investors on Wednesday, Marketbeat.com reports. They currently have a $35.00 price target on the scientific and technical instruments company’s stock, down from their previous price target of $45.00. JPMorgan Chase & Co.‘s price objective points to a potential downside of 10.03% from the company’s current price.

Several other brokerages also recently issued reports on CGNX. KeyCorp restated an “overweight” rating and issued a $50.00 price objective on shares of Cognex in a research report on Friday, October 31st. DA Davidson set a $38.00 target price on shares of Cognex and gave the company a “neutral” rating in a report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a research note on Monday. Robert W. Baird set a $45.00 price objective on shares of Cognex in a research report on Friday, October 31st. Finally, Needham & Company LLC raised their target price on shares of Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $45.53.

Cognex Price Performance

Shares of NASDAQ CGNX opened at $38.90 on Wednesday. The firm’s 50-day moving average is $42.09 and its two-hundred day moving average is $38.73. The company has a market capitalization of $6.52 billion, a PE ratio of 60.78 and a beta of 1.53. Cognex has a 12-month low of $22.67 and a 12-month high of $49.76.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.06. The firm had revenue of $264.00 million during the quarter, compared to the consensus estimate of $261.86 million. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The company’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.20 EPS. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. On average, analysts forecast that Cognex will post 0.61 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Robert Willett sold 6,704 shares of the business’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total transaction of $331,915.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the sale, the executive vice president owned 6,582 shares of the company’s stock, valued at approximately $296,387.46. The trade was a 23.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cognex

Several hedge funds and other institutional investors have recently modified their holdings of CGNX. Quent Capital LLC acquired a new stake in Cognex during the 3rd quarter worth approximately $26,000. REAP Financial Group LLC purchased a new stake in Cognex during the third quarter worth approximately $27,000. Geneos Wealth Management Inc. increased its position in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares in the last quarter. Penserra Capital Management LLC purchased a new position in shares of Cognex in the 2nd quarter valued at $29,000. Finally, TD Waterhouse Canada Inc. acquired a new position in shares of Cognex during the 2nd quarter valued at $29,000. 88.12% of the stock is owned by institutional investors and hedge funds.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.